VHL alterations in human clear cell renal cell carcinoma: Association with advanced tumor stage and a novel hot spot mutation

Cancer Research

Volumn 60, Issue 7, 2000, Pages 1942-1948

  Brauch, Hiltrud ^a   Weirich, Gregor ^b,c   Brieger, Jürgen ^d   Glavač, Damjan ^e   Rödl, Heinz ^b   Eichinger, Mariola ^b   Feurer, Matthias ^b   Weidt, Eberhardt ^d   Puranakanitstha, Chutintorn ^d   Neuhaus, Christine ^d   Pomer, Sigmund ^f   Brenner, Walburgis ^d   Schirmacher, Peter ^d   Störkel, Stephan ^g   Rotter, Michael ^b   Mašera, Andrej ^e   Gugeler, Nadja ^a   Decker, Hans Joachim ^d,h  

^a DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c NATIONAL CANCER INSTITUTE   (United States)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

^e UNIVERSITY OF LJUBLJANA   (Slovenia)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g UNIVERSITY OF WITTEN HERDECKE   (Germany)

^h Bioscientia Center for Human Genetics   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; UNCLASSIFIED DRUG; VON HIPPEL LANDAU GENE PRODUCT;

ADVANCED CANCER; ARTICLE; CLEAR CELL CARCINOMA; DNA METHYLATION; GENE MUTATION; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; ONCOCYTOMA; PAPILLARY CARCINOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

ADENOMA, OXYPHILIC; AMINO ACID SUBSTITUTION; CARCINOMA, RENAL CELL; DNA METHYLATION; DNA, NEOPLASM; FRAMESHIFT MUTATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; KIDNEY; KIDNEY NEOPLASMS; LIGASES; MUTATION; NEOPLASM STAGING; POINT MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTEINS; SEQUENCE DELETION; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 16744366213     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Latif, F., Tory, K., Gnarra, J., Yao, M., Dun, F. M., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., Schmidt, L., Zhou, F., Li, H., Wei, M. H., Chen, F., Glenn, G., Choyke, P., Walther, M. M., Weng, Y., Duan, D. S. R., Dean, M., Glavac, D., Richards, F. M., Crossey, P. A., Ferguson-Smith, M. A., Le Paslier, D., Chumakov, I., Cohen, D., Chinault, A. C., Maher, E. R., Linehan, W. M., Zbar, B., and Lerman, M. I. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science (Washington DC), 260: 1317-1320, 1993.
2. Zbar, B., Kishida, T., Chen, F., Schmidt, L., Maher, E. R., Richards, F. M., Crossey, P. A., Webster, A. R., Affara, N. A., Ferguson-Smith, M. A., Brauch, H., Glavac, D., Neumann, H. P. H., Tisherman, S., Mulvehill, J., Gross, D., Shuin, T., Whaley, J., Seizinger, B., Kley, N., Olschwang, S., Boisson, C., Richard, S., Lips, C. H. M., Linehan, W. M., and Lerman, M. I. Germline mutations in the von Hippel-Lindau disease gene (VHL) in families from North America, Europe, and Japan. Hum. Mutat., 8: 348-357, 1996.
3. Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., Wei, M. W., Li, H., Latif, F., Liu, S., Chen, F., Duh, F. M., Lubensky, I., Duan, D. R., Florence, C., Pozzati, R., Walther, M. M., Bander, N. H., Grossman, H. B., Brauch, H., Pomer, S., Brooks, J. D., Isaacs, W. B., Lerman, M. I., Zbar, B., and Linehan, W. M. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat. Genet., 7: 85-90, 1994.
4. Zbar, B., Brauch, H., Talmadge, C., and Linehan, M. Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature (Lond.), 327: 721-724, 1987.
5. Foster, K., Prowse, A., van den Bergh, A., Fleming, S., Hulsbeek, M. M. F., Crossey, P. A., Richards, F. M., Cairns, P., Affara, N. A., Ferguson-Smith, M. A., Buys, C. H. C. M., and Maher, E. R. Somatic mutations of the von Hippel-Lindau disease tumor suppressor gene in non-familial clear cell renal carcinoma. Hum. Mol. Genet., 3: 2169-2173, 1994.
6. Shuin, T., Kondo, K., Torigoe, S., Kishida, T., Kubota, Y., Hosaka, M., Nagashima, Y., Kitamura, H., Latif, F., Zbar, B., Lerman, M. I., and Yao, M. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinoma. Cancer Res., 54: 2852-2855, 1994.
7. Whaley, J. M., Naglich, J., Gelbert, L., Hsia, Y. E., Lamiell, J. M., Green, J. S., Collins, D., Neumann, H. P. H., Laidlaw, J., Li, F. P., Klein-Szanto, A. J. P., Seizinger, B., and Kley, N. Germline mutations in the von Hippel-Lindau tumor suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma. Am. J. Hum. Genet., 55: 1092-1102, 1994.
8. Kenck, C., Wilhelm, M., Bugert, P., Staehler, G., and Kovacs, G. Mutations of the VHL gene is associated exclusively with the development of non-papillary renal cell carcinomas. J. Pathol., 179: 157-161, 1996.
9. Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D. S. R., Gnarra, J. R., Linehan, W. M., and Baylin, S. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA, 91: 9700-9704, 1994.
10. Pause, A., Lee, S., Worrell, R., Chen, D. Y. T., Burgess, W. H., Linehan, W. M., and Klausner, R. D. The von Hippel-Lindau tumor suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins. Proc. Natl. Acad. Sci. USA, 94: 2156-2161, 1997.
11. Gorospe, M., Egan, J. M., Zbar, B., Lerman, M. I., Geil, L., Kuzmin, I., and Holbrook, N. J. Protective function of the von Hippel-Lindau protein against impaired protein processing in renal carcinoma cells. Mol. Cell. Biol., 19: 1289-1300, 1999.
12. Siemeister, G., Weindel, K., Mohrs, K., Barleon, B., Martiny-Baron, G., and Marme, D. Reversion of deregulated expression of vascular endothelial growth factor in human renal cell carcinoma cells by von Hippel-Lindau tumor suppressor protein. Cancer Res., 56: 2299-2301, 1996.
13. Maxwell, P. H., Wiesener, M. S., Chang, G-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., and Ratcliffe, P. J. The tumor suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature (Lond.), 399: 271-275, 1999.
14. Ivanov, S. V., Kuzmin, I., Wei, M. H., Pack, S., Geil, L., Johnson, B. E., Stanbridge, E. J., and Lerman, M. I. Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes. Proc. Natl. Acad. Sci. USA, 95: 12596-12601, 1998.
15. Ohh, M., Yauch, R. L., Lonergan, K. M., Whaley, J. M., Stemmer-Rachmamimov, A. O., Louis, D. N., Gavin, B. J., Kaelin, W. G., Jr., and Iliopoulos, O. The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix. Mol. Cell, 1: 959-968, 1998.
16. Brauch, H., Weirich, G., Hornauer, M. A., Störkel, S., Wöhl, T., and Brüning, T. Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma. J. Natl. Cancer Inst., 91: 854-861, 1998.
17. Parkin, D. M., Muir, C. S., Whelan, S. L., Gao, Y-T., Ferlay, J., and Powell, J. Cancer Incidence in Five Continents. VI. IARC Scientific Publication No. 120. Lyon, France: IARC, 1992.
18. Thoenes, W., Störkel, S., and Rumpelt, H. J. Histopathology and classification of renal cell tumors (adenomas, renal oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Path. Res. Pract., 181: 125-143, 1986.
19. Störkel, S., Eble, J. N., Adlakha, K., Amin, M., Blute, M. L., Bostwick, D. G., Darson, M., Delahunt, B., and Iczkowski, K. Classification of renal cell carcinoma. Workgroup No. 1, Union Internationale Contre Le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80: 987-989, 1997.
20. TNM Atlas Illustrated Guide to the TNM/pTNM Classification of Malignant Tumours. Int. Union Against Cancer - Union Internationale Contre le Cancer, Ed. 3. Berlin: Springer Verlag, 1992.
21. Glavac, D., Neumann, H. P. H., Wittke, C., Jähnig, H., Rödl, H., Masek, O., Streicher, T., Pausch, F., Engelhardt, D., Plate, K., Höfler, H., Chen, F., Zbar, B., and Brauch, H. Mutations in the VHL tumor suppressor gene and associated lesions with von Hippel-Lindau disease from Central Europe. Hum. Genet., 98: 271-280, 1996.
22. Chen, F., Kishida, T., Yao, M., Hustad, T., Glavac, D., Dean, M., Gnarra, J. R., Orcutt, M. L., Duh, F. M., Glenn, G., Green, J., Hsia, E. Lamiell, J., Li, H., Wei, M. H., Schmidt, L., Tory, K., Kuzmin, I., Stackhouse, T., Latif, F., Linehan, M. W., Lerman, M. I., and Zbar, B. Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum. Mutat., 5: 66-75, 1995.
23. Stolle, C., Glenn, G., Zbar, B., Humphrey, J. S., Choyke, P., Walther, M., Pack, S., Hurley, K., Andrey, C., Klausner, R., and Linehan, W. M. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum. Mutat., 12: 417-423, 1998.
24. Brauch, H., Kishida, T., Glavač, D., Chen, F., Pausch, F., Höfler, H., Lerman, M. I., Zbar, B., and Neumann, H. P. H. Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region in Germany: evidence for a founder effect. Hum. Genet., 95: 551-556, 1995.
25. Brauch, H., Pomer, S., Hieronymus, T., Schadt, T., Löhrke, H., and Komitowski, D. Genetic alterations in sporadic renal-cell carcinoma: molecular analyses of tumor suppressor gene harboring chromosomal regions 3p, 5q, and 17p. World J. Urol., 12: 162-168, 1994.
26. Stokes, M. E., Davis, C. S., and Koch, G. G. Categorical Data Analysis Using the SAS System, p. 499. Cary, NC: SAS Institute, Inc., 1995.
27. Becker, N., and Wahrendorf, J. Atlas of Cancer Mortality in the Federal Republic of Germany 1981-1990, Ed. 3. (Krebsatlas der Bundesrepublik Deutschland 1981-1990, Ed. 3.) Berlin: Springer Verlag, 1998.
28. McLaughlin, J. K., and Schuman, L. M. Epidemiology of renal carcinoma. In: A. M. Lilienfeld (ed.), Reviews in Cancer Epidemiology, pp. 170-210. New York: Elsevier, 1983.
29. Stebbins, C. E., Kaelin, W. G., Jr., and Pavletich, N. P. Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. Science (Washington DC), 284: 455-461, 1999.
30. Kibel, A. Iliopoulos, O., DeCaprio, J. A., and Kaelin, W. G., Jr. Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C. Science (Washington DC), 269: 1444-1446, 1995.
31. Ward, J. F. DNA damage produced by ionizing radiation in mammalian cells: identities, mechanisms of formation, and reparability. Prog. Nucleic Acid Res. Mol. Biol., 35: 95-125, 1988.
32. Singer, B. O-Alkyl pyrimidines in mutagenesis and carcinogenesis: occurrence and significance. Cancer Res., 46: 4879-4885, 1986.
33. Setlow, R. B. Cyclobutane-type pyrimidine dimers in polynucleotides. Science (Washington DC), 153: 379-386, 1966.
34. 6 position of guanine in DNA is the most likely initiating event in carcinogenesis by methylating agents. Cancer Investig., 2: 223-231, 1984.
35. van den Berg, A., and Buys, C. H. Involvement of multiple loci on chromosome 3 in renal cell cancer development. Genes Chromosomes Cancer, 19: 59-79, 1997.
36. Schmidt, L., Duh, F. M., Chen, F., Kishida, T., Glenn, G., Choyke, P., Scherer, S. W., Zhuang, Z., Lubensky, I., Dean, M., Allikmets, R., Chidambaram, A., Bergerheim, U. F., Feltis, J. T., Casadevall, C., Zamarron, A., Bernues, M., Richard, S., Lips, C. J. M., Walther, M. M., Tsui, L. C., Geil, L., Orcutt, M. L., Stackhouse, T., Lipan, J., Slife, L., Brauch, H., Decker, J., Niehans, G., Hughson, M. D., Moch, H., Störkel, S., Lerman, M. I., Linehan, W. M., and Zbar, B. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat. Genet., 16: 68-73, 1997.
37. Schmidt, L., Junker, K., Nakaigawa, N., Kinjerski, T., Weirich, G., Miller, M., Lubensky, I., Neumann, H. P. H., Brauch, H., Decker, J., Vocke, C., Brown, J. A., Jenkins, R., Richard, S., Bergerheim, U., Gerrard, B., Dean, M., Linehan, W. M., and Zbar, B. Novel mutations in the MET proto-oncogene in papillary renal carcinomas. Oncogene, 18: 2343-2350, 1999.
38. Lubensky, I. A., Schmidt, L., Zhuang, Z., Weirich, G., Pack, S., Zambrano, N., Walther, M. M., Choyke, P., Linehan, W. M., and Zbar, B. Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype. Am. J. Pathol. 155: 517-526, 1999.
39. Neumann, H. P. H., Bender, B. U., Berger, D. P., Laubenberger, J., Schultze-Seemann, W., Wetterauer, U., Ferstl, F. J., Herbst, E. W., Schwarzkopf, G., Hes, F. J., Lips, C. J. M., Lamiell, J. M., Masek, O., Riegler, P., Mueller, B., Glavač, D., and Brauch, H. Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinoma. J. Urol., 160: 1248-1254, 1998.
40. Thoenes, W., Störkel, S., Rumpelt, H. J., Moll, R., Baum, H. P., and Werner, S. Chromophobe cell renal carcinomas and its variants - a report on 32 cases. J. Pathol., 155: 277-287, 1988.
41. Crotty, T. B., Farrow, G. M., and Lieber, M. M. Chromophobe cell renal carcinoma: clinicopathological features of 50 cases. J. Urol., 154: 964-967, 1996.